175 related articles for article (PubMed ID: 27847916)
1. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea.
Lee YJ; Lee JW; Park J; Seo SI; Chung JI; Yoo TK; Son H
Investig Clin Urol; 2016 Nov; 57(6):424-430. PubMed ID: 27847916
[TBL] [Abstract][Full Text] [Related]
2. Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data.
Morton A; Williams M; Perera M; Teloken PE; Donato P; Ranasinghe S; Chung E; Bolton D; Yaxley J; Roberts MJ
BJU Int; 2020 Sep; 126 Suppl 1():18-26. PubMed ID: 32558340
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.
Park J; Lee YJ; Lee JW; Yoo TK; Chung JI; Yun SJ; Hong JH; Seo SI; Cho SY; Son H
Korean J Urol; 2015 Mar; 56(3):233-9. PubMed ID: 25763128
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
Verhamme KM; Dieleman JP; Bleumink GS; van der Lei J; Sturkenboom MC; Artibani W; Begaud B; Berges R; Borkowski A; Chappel CR; Costello A; Dobronski P; Farmer RD; Jiménez Cruz F; Jonas U; MacRae K; Pientka L; Rutten FF; van Schayck CP; Speakman MJ; Sturkenboom MC; Tiellac P; Tubaro A; Vallencien G; Vela Navarrete R;
Eur Urol; 2002 Oct; 42(4):323-8. PubMed ID: 12361895
[TBL] [Abstract][Full Text] [Related]
5. Optimal high-density lipoprotein cholesterol level for decreasing benign prostatic hyperplasia in men not taking statin medication: A historical cohort study.
Yoo S; Oh S; Suh J; Park J; Cho MC; Jeong H; Won S; Son H
Prostate; 2020 May; 80(7):570-576. PubMed ID: 32196725
[TBL] [Abstract][Full Text] [Related]
6. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
[TBL] [Abstract][Full Text] [Related]
7. Medication Discontinuation Following Transurethral Prostatectomy: an Unrecognized Effectiveness Measure?
Campbell RA; Gill BC
Curr Urol Rep; 2020 Nov; 21(12):61. PubMed ID: 33159617
[TBL] [Abstract][Full Text] [Related]
8. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
9. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
[TBL] [Abstract][Full Text] [Related]
10. Systemic Comorbidity Burden Using the ACTIONS Phenotype Predicts Urologic Medication Discontinuation Following Transurethral Resection of the Prostate.
Zhang JH; Gill BA; Wilkins L; Ramkumar RR; Shoskes DA
Urology; 2019 May; 127():91-96. PubMed ID: 30822484
[TBL] [Abstract][Full Text] [Related]
11. Real-world data and treatment patterns of patients with lower urinary tract symptoms due to benign prostatic hyperplasia in Germany: an observational study using health insurance claims data.
Miernik A; Fritzsche J; Libutzki B; Malka V; Kilemnik I; Mohebbi D; May M; Gratzke C; Suarez-Ibarrola R
World J Urol; 2021 Dec; 39(12):4381-4388. PubMed ID: 34292368
[TBL] [Abstract][Full Text] [Related]
12. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
13. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: urodynamic effects.
Van Melick HH; Van Venrooij GE; Eckhardt MD; Boon TA
J Urol; 2002 Sep; 168(3):1058-62. PubMed ID: 12187222
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Long-term Effect and Complications Between Holmium Laser Enucleation and Transurethral Resection of Prostate: Nations-Wide Health Insurance Study.
Kim A; Hak AJ; Choi WS; Paick SH; Kim HG; Park H
Urology; 2021 Aug; 154():300-307. PubMed ID: 33933503
[TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
[TBL] [Abstract][Full Text] [Related]
17. The impacts of metabolic syndrome and lifestyle on the prevalence of benign prostatic hyperplasia requiring treatment: historical cohort study of 130 454 men.
Yoo S; Oh S; Park J; Cho SY; Cho MC; Jeong H; Son H
BJU Int; 2019 Jan; 123(1):140-148. PubMed ID: 30125452
[TBL] [Abstract][Full Text] [Related]
18. Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia.
Hou CP; Lin YH; Chen TH; Chang PL; Juang HH; Chen CL; Yang PS; Tsui KH
Aging Male; 2018 Mar; 21(1):9-16. PubMed ID: 28763255
[TBL] [Abstract][Full Text] [Related]
19. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
20. Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study.
Peng YH; Huang CW; Liao WC; Chen HJ; Yin MC; Huang YM; Wu TN; Ho WC
BMJ Open; 2017 Jun; 7(6):e015581. PubMed ID: 28645971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
